TY - JOUR T1 - Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review. AU - Wang,Xin-Shi, AU - Zhang,Zeng-Rui, AU - Zhang,Man-Man, AU - Sun,Miao-Xuan, AU - Wang,Wen-Wen, AU - Xie,Cheng-Long, Y1 - 2017/08/17/ PY - 2017/02/06/received PY - 2017/08/11/accepted PY - 2017/8/19/entrez PY - 2017/8/19/pubmed PY - 2017/9/2/medline KW - Animal models KW - Curcumin KW - Parkinson’s disease KW - Preclinical studies KW - Systematic review SP - 412 EP - 412 JF - BMC complementary and alternative medicine JO - BMC Complement Altern Med VL - 17 IS - 1 N2 - BACKGROUND: Curcumin (diferuloylmethane), a polyphenol extracted from the plant Curcuma longa, is widely used in Southeast Asia, China and India in food preparation and for medicinal purposes. Meanwhile, the neuroprotective actions of curcumin have been documented for experimental therapy in Parkinson's disease (PD). METHODS: In this study, we used a systematic review to comprehensively assess the efficacy of curcumin in experimental PD. Using electronic and manual search for the literatures, we identified studies describing the efficacy of curcumin in animal models of PD. RESULTS: We identified 13 studies with a total of 298 animals describing the efficacy of curcumin in animal models of PD. The methodological quality of all preclinical trials is ranged from 2 to 5. The majority of the experiment studies demonstrated that curcumin was more significantly neuroprotection effective than control groups for treating PD. Among them, five studies indicated that curcumin had an anti-inflammatory effect in the PD animal models (p < 0.05). Meanwhile, four studies showed the antioxidant capability of curcumin, by which it protected substantia nigra neurons and improved striatal dopamine levels. Furthermore, two studies in this review displayed that curcumin treatment was also effective in reducing neuronal apoptosis and improving functional outcome in animal models of PD. Most of the preclinical studies demonstrated the positive findings while one study reported that curcumin had no beneficial effects against Mn-induced disruption of hippocampal metal and neurotransmitter homeostasis. CONCLUSIONS: The results demonstrated a marked efficacy of curcumin in experimental model of PD, suggesting curcumin probably a candidate neuroprotective drug for human PD patients. SN - 1472-6882 UR - https://www.unboundmedicine.com/medline/citation/28818104/Neuroprotective_properties_of_curcumin_in_toxin_base_animal_models_of_Parkinson's_disease:_a_systematic_experiment_literatures_review_ L2 - https://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-017-1922-x DB - PRIME DP - Unbound Medicine ER -